Patents by Inventor Cheng-Chia YU

Cheng-Chia YU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11058746
    Abstract: The present invention provides a method of preventing or treating fibrosis in a subject, comprising administering an effective amount of an immunomodulatory protein derived from Ganoderma lucidum, Ganoderma lucidum, Ganoderma tsugae, Ganoderma microsporum or Ganoderma sinensis to the subject, thereby preventing or treating a fibrosis.
    Type: Grant
    Filed: September 25, 2017
    Date of Patent: July 13, 2021
    Assignee: MYCOMAGIC BIOTECHNOLOGY CO., LTD.
    Inventor: Cheng-Chia Yu
  • Publication number: 20190091286
    Abstract: The present invention provides a method of preventing or treating fibrosis in a subject, comprising administering an effective amount of an immunomodulatory protein derived from Ganoderma lucidum, Ganoderma lucidum, Ganoderma tsugae, Ganoderma microsporum or Ganoderma sinensis to the subject, thereby preventing or treating a fibrosis.
    Type: Application
    Filed: September 25, 2017
    Publication date: March 28, 2019
    Inventor: CHENG-CHIA YU
  • Patent number: 9937226
    Abstract: The present invention relates to a new use of an immunomodulatory protein derived from Ganoderma or a recombinant or a composition thereof in inhibiting cancel stem cells. Particularly, the immunomodulatory protein is derived form Ganoderma microsporum and the cancel stem cell is oral cancer stem cell.
    Type: Grant
    Filed: December 29, 2015
    Date of Patent: April 10, 2018
    Assignee: MYCOMAGIC BIOTECHNOLOGY CO., LTD.
    Inventor: Cheng-Chia Yu
  • Publication number: 20160184389
    Abstract: The present invention relates to a new use of an immunomodulatory protein derived from Ganoderma or a recombinant or a composition thereof in inhibiting cancel stem cells. Particularly, the immunomodulatory protein is derived form Ganoderma microsporum and the cancel stem cell is oral cancer stem cell.
    Type: Application
    Filed: December 29, 2015
    Publication date: June 30, 2016
    Inventor: Cheng-Chia Yu
  • Publication number: 20130053449
    Abstract: A method for inhibiting at least one of histone gene transcription and histone expression in a subject is provided.
    Type: Application
    Filed: November 18, 2011
    Publication date: February 28, 2013
    Applicant: CHINA MEDICAL UNIVERSITY
    Inventors: Tzong-Ming SHIEH, Cheng-Chia YU, Shih-Min HSIA